GAD autoantibodies are also detected in disease other than SPS and autoimmune diabetes, such as epilepsy, cerebellar ataxia, myoclonus, myasthenia gravis, or other neurological disorders (16, 21). This evidence concerns the gene GAD1 and Myoclonus.